(Finance) – Dimainvest, the company of the founder Umberto Di Maio who is the main shareholder with 85.59% of the capital, has decided to voluntarily promote apublic purchase offer (OPA) on all of the ordinary shares of Shedir Pharmaa group listed on Euronext Growth Milan and active in the field of nutraceuticals and pharmaceuticals. The takeover bid is aimed at delisting from Piazza Affari.
The bidder will acknowledge a fee equal to 4.90 euros for each tendered share, which incorporates a premium of 18.36% compared to the last reference price of 6 November 2024. The company was listed in July 2019 with an IPO price of 7 euros per share.
The offeror believes that the offer is instrumental to the pursuit of future growth programs and the strengthening of the company, to the extent that the delisting would allow the latter to pursue its objectives in a market context and in a legal framework characterized from greater managerial and organizational flexibility, with faster decision and execution times and also benefiting from a reduction of management costs.